From controversy to consensus: A timeline of prone positioning trials in ARDS
By Tara Psencik, BSN RN
Prone positioning—once a debated intervention in the management of Acute Respiratory Distress Syndrome (ARDS)—has evolved into a cornerstone of modern critical care. While its oxygenation benefits were recognized early on, its impact on mortality took over a decade to become clear.
It’s been over 12 years since the PROSEVA trial demonstrated a dramatic reduction in mortality with early, prolonged prone positioning for severe ARDS—yet in many hospitals, proning is still treated as a last resort, or not used at all.
Why the disconnect? Because it’s hard? Because therapies without endpoint mortality data receive better reimbursement? (Doesn’t the Hippocratic Oath still apply?) Because of staff inexperience? Because patients have high BMIs?
This blog traces the key clinical trials and meta-analyses that shaped our understanding of prone positioning, from skepticism to standard of care.
Timeline of Key Prone Positioning Trials
Year Study / Authors Population Key Findings
2001 Guerin et al. (NEJM) ARDS (n=304) Improved oxygenation, but no mortality benefit. Sessions were short (~7 hrs/day).
2004 Taccone et al. (JAMA) Severe ARDS (n=791) No mortality reduction; higher risk of complications like pressure ulcers.
2006 Gattinoni et al. (NEJM) ARDS (n=341) No survival benefit compared to supine ventilation; proning time still limited (~7 hrs/day).
2013 PROSEVA Trial (Guerin et al., NEJM) Severe ARDS (n=466) Landmark trial: Proning ≥16 hrs/day + low tidal volume ventilation → 41% relative reduction in 28-day mortality (16% vs. 32.8%).
2014 Sud et al. Meta-analysis Meta-analysis (n=2,100+) Mortality benefit seen only in trials using prolonged prone positioning and lung-protective ventilation.
2020 COVID-19 Pandemic Global (intubated & awake patients) Widespread adoption of prone positioning, including for non-intubated patients with hypoxemia.
2021 Alhazzani et al. / Weiss et al. (COVID-PRONE) Non-intubated COVID-19 Awake proning reduced intubation rates but showed no clear mortality benefit.
2022 Meta-Trial (Ehrmann et al., Lancet Respir Med) COVID-19 hypoxemia (n=1,126) Confirmed awake proning lowers intubation risk in patients on high-flow nasal cannula; no difference in mortality.
2023 Wang et al. (BMC Pulmonary Medicine) Surgical/trauma ARDS Prone ventilation significantly improved oxygenation and reduced mortality (RR = 0.48).
Summary of Evolution
- Early 2000s: Initial trials showed oxygenation improvement, but failed to demonstrate a survival advantage. This was likely due to short proning durations and lack of standardized ventilatory strategies.
- 2013 – PROSEVA Trial: A true game changer. By combining prolonged prone sessions (≥16 hrs/day) with lung-protective ventilation, the PROSEVA trial demonstrated >50% reduction in 28-day mortality and 41% reduction in 90-day mortality among patients with severe ARDS. This landmark study established prone positioning as standard of care rather than an optional intervention.
- COVID-19 Era (2020–2022): The pandemic revitalized interest in awake prone positioning. While it didn’t show a consistent mortality benefit, it reduced the need for intubation in many hypoxemic patients. This non-invasive strategy became especially valuable in resource-limited settings.
Takeaway
The evidence is clear: early and prolonged prone positioning saves lives in moderate to severe ARDS when applied correctly. While some other advanced and salvage therapies have their place, prone positioning remains one of the most effective, low-cost interventions available in critical care.
As we look to the future, integrating prone positioning earlier and more consistently—alongside evolving respiratory support strategies—will continue to shape better outcomes for ARDS patients worldwide.
At Turn Medical, we’re passionate about transforming prone positioning from an international standard of care into a true standard of practice.
The challenges are real—but they’re exactly why we’re here.
Turn Medical is committed to changing the paradigm. Our goal is to help critical care teams adopt early, safe, and effective proning—reducing preventable injuries to staff and improving outcomes for patients with ARDS.
As we look to the future, integrating prone positioning earlier and more consistently—alongside evolving respiratory support strategies—will continue to shape better outcomes for ARDS patients worldwide.
Contact us today for expert support with your proning protocols—and to connect with other hospitals already achieving positive outcomes using Pronova-O2.
References:
Guérin, C., Gaillard, S., Lemasson, S., Ayzac, L., Girard, R., Beuret, P., … & Richard, J. C. M. (2001). Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. New England Journal of Medicine, 344(8), 568–573. https://doi.org/10.1056/NEJM200102223440802
Taccone, P., Pesenti, A., Latini, R., Polli, F., Vagginelli, F., Russo, E., … & Gattinoni, L. (2009). Prone positioning in patients with moderate and severe acute respiratory distress syndrome: A randomized controlled trial. JAMA, 302(18), 1977–1984. https://doi.org/10.1001/jama.2009.1614 (Note: Though your timeline lists this as 2004, Taccone et al.’s key prone trial in JAMA was 2009.)
Gattinoni, L., Tognoni, G., Pesenti, A., Taccone, P., Mascheroni, D., Labarta, V., … & Prone-Supine Study Group. (2001). Effect of prone positioning on the survival of patients with acute respiratory failure. New England Journal of Medicine, 345(8), 568–573. https://doi.org/10.1056/NEJMoa010043
Guérin, C., Reignier, J., Richard, J. C., Beuret, P., Gacouin, A., Boulain, T., … & Ayzac, L. (2013). Prone positioning in severe acute respiratory distress syndrome. New England Journal of Medicine, 368(23), 2159–2168. https://doi.org/10.1056/NEJMoa1214103
Sud, S., Friedrich, J. O., Taccone, P., Polli, F., Adhikari, N. K. J., Latini, R., … & Ferguson, N. D. (2010). Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Medicine, 36, 585–599. https://doi.org/10.1007/s00134-009-1748-1 (Note: Although published in 2010, the meta-analysis evaluated studies up to 2009.)
Ehrmann, S., Li, J., Ibarra-Estrada, M., Perez, Y., Pavlov, I., McNicholas, B., … & Fergusson, N. A. (2021). Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomized, controlled, multinational, open-label meta-trial. The Lancet Respiratory Medicine, 9(12), 1387–1395. https://doi.org/10.1016/S2213-2600(21)00356-8
Weiss, T. T., Cerda, F., Scott, J. B., Trenker, T., Vuong, H., … & Alhazzani, W. (2021). Prone positioning for awake, nonintubated patients with COVID-19 hypoxemic respiratory failure: a systematic review and meta-analysis. Critical Care Explorations, 3(9), e0531. https://doi.org/10.1097/CCE.0000000000000531
Wang, J., Du, Z., Gu, W., Wu, C., Zhang, S., & Zhang, J. (2023). Effects of prone position ventilation in patients with acute respiratory distress syndrome after major trauma or surgery: A retrospective study. BMC Pulmonary Medicine, 23, 21. https://doi.org/10.1186/s12890-023-02381-4
